

Effectiveness of complex treatment of tube-peritoneal infertility with the use of immunomodulatory therapy
https://doi.org/10.30629/0023-2149-2024-102-8-652-654
Abstract
Objective: To evaluate the effectiveness of comprehensive treatment for tubo-peritoneal infertility using immunomodulators and to compare the results obtained with literature data presenting classical therapy schemes for this type of infertility. Material and Methods: A retrospective study using a targeted sampling method. A total of 97 protocols for laparoscopic surgeries on patients with a clinical diagnosis of “Female infertility of tube-peritoneal origin. Chronic salpingitis and oophoritis” were examined. Results: Pregnancy occurred in 77.3% of patients, with 69.4% conceiving within the first year after surgery, and among these, 44.2% within the first 6 months (p < 0.05). Conclusions: As a result of comprehensive treatment using active immunomodulatory therapy, pregnancy occurred in 77.3% of cases, which is a statistically significant indicator for this sample (p < 0.05) and reflects the high effectiveness of the therapy conducted. Based on the results obtained, it is possible to state a significant impact of active immunotherapy on the outcomes of treatment for female infertility associated with the tubal factor. This is most clearly visible when compared with literature data, where in classical treatment schemes, the pregnancy rate within one year varied from 38 to 44% (whereas in the first year after therapy, pregnancy occurred in only 13–15% of cases).
About the Authors
T. A. IvanovaRussian Federation
Taisiya A. Ivanova — a 6th year student
Tver
M. Ya. Kogan
Russian Federation
Mikhail Ya. Kogan — obstetrician-gynecologist, Honored Doctor of the Russian Federation
Tver
Yu. S. Nechaeva
Russian Federation
Yulia S. Nechaeva — Assistant at the Department of Obstetrics and Gynecology
Tver
I. L. Petushkov
Russian Federation
Ivan L. Petushkov — 6th year student
Moscow
References
1. Avrukevich E.A. Tube-peritoneal infertility: diagnosis and treatment. Smolensk medical almanac. 2017;1:17–20. (In Russian)].
2. Dicke G.B., Vasilenko G.I. Tubular-peritoneal infertility in women. Possibilities of increasing the eff ectiveness of treatment. Obstetrics and gynecology. 2016;9:119–125. (In Russian)].
3. Ten Broek RP., Stommel M.W., Strik C. et al. Benefi ts and harms of adhesion barriers for abdominal surgery: a systematic review and metaanalysis. Lancet. 2014;383:48–59.
4. Yakovleva N.V. Surgical treatment of tube infertility: problems and solutions. Bulletin of new medical technologies. 2014;20(1):121–127. (In Russian)].
5. Grigoryan E.S. et al. Tubularperitoneal form of infertility: etiology, risk factors, modern methods of treatment. Mother and child in Kuzbass. 2019;2:10–14. (In Russian)].
6. Dovletkhanova E.R. Possibility of application of immunomodulators in complex treatment ZMT. Medical Council. 2012;12:84–87. (In Russian)].
7. Jayioba O., Lesenbi G., Soper D.E. Recommendations for the treatment of infl ammatory diseases of the pelvic organs. Obstetrics and gynecology. News. Opinions. Training. 2013;1(1):43–54. (In Russian)].
8. Urakova N.A. Ipatova T.V. Immunotherapy as a way to increase the eff ectiveness of complex treatment of infl ammatory diseases of pelvic organs. RMJ. Mother and child. 2018;1(2):120–123. (In Russian)].
9. Gasparov A.S., Dubinskaya E.D. Pelvic peritoneal adhesives: etiology, pathonesis, diagnosis, prevention. M. Medical News Agency. 2013. (In Russian)].
10. Romashchenko O.V., Vosiyanova S.V., Rudenko A.V., Yakovenko L.F. Treatment of infl ammatory diseases of the pelvic organs caused by a mixt infection. Zdorovieh woman. 2016;6(112):134. (In Russian)].
11. Mutsaer S.E., Prêle C.M., Pengelly S. et al. Mesothelial cells and peritoneal homeostasis. Fertil. Steril. 2016;106(5):1018–24.
12. Rocca A, Aprea G, Surfaro G et al. Prevention and treatment of peritoneal adhesions in patients aff ected by vascular diseases following surgery: a review of the literature. Open Med. (Wars). 2016;11(1):106–14.
13. Sulima A., Davydova A., Litvinov V. Proinfl ammatory cytokines TNF-a and IL-1 in pelvic peritoneal adhesions of various etiology at reproductive age women. 32nd Annual Meeting of ESHRE. Helsinki. 2016;31(1):463–4.
14. Gomel V., Koninckx P.R. Microsurgical principles and postoperative adhesions: lessons from the past. Fertil. Steril. 2016;106(5):1025–31.
15. Arung W., Drion P., Cheramy J.P. et al. Intraperitoneal adhesions after open or laparoscopic abdominal procedure: an experimental study in the rat. J. Laparoendosc. Adv. Surg. Tech. A. 2012;22:651–7.
16. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery. The Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society of Reproductive Surgeons. Fertil. Steril. 2013;99(6):1550–5
Review
For citations:
Ivanova T.A., Kogan M.Ya., Nechaeva Yu.S., Petushkov I.L. Effectiveness of complex treatment of tube-peritoneal infertility with the use of immunomodulatory therapy. Clinical Medicine (Russian Journal). 2024;102(8):652-654. (In Russ.) https://doi.org/10.30629/0023-2149-2024-102-8-652-654